Ambit Biosciences Company
Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Estimated Revenue:
$10M to $50M
Headquarters:
San Diego, California, United States
Founded Date:
2000
Last Funding Date:
2012-11-06
Industry:
PharmTech
Investors Number:
15
Employee Number:
51-100
Funding Status:
M&A
Total Funding:
215727869 USD
Last Funding Type:
Venture - Series Unknown
Technology:
Immunotherapy